1. Home
  2. RCUS vs SPB Comparison

RCUS vs SPB Comparison

Compare RCUS & SPB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RCUS
  • SPB
  • Stock Information
  • Founded
  • RCUS 2015
  • SPB 1906
  • Country
  • RCUS United States
  • SPB United States
  • Employees
  • RCUS N/A
  • SPB N/A
  • Industry
  • RCUS Biotechnology: Pharmaceutical Preparations
  • SPB Industrial Machinery/Components
  • Sector
  • RCUS Health Care
  • SPB Miscellaneous
  • Exchange
  • RCUS Nasdaq
  • SPB Nasdaq
  • Market Cap
  • RCUS 1.2B
  • SPB 1.3B
  • IPO Year
  • RCUS 2018
  • SPB N/A
  • Fundamental
  • Price
  • RCUS $12.20
  • SPB $56.91
  • Analyst Decision
  • RCUS Buy
  • SPB Strong Buy
  • Analyst Count
  • RCUS 8
  • SPB 4
  • Target Price
  • RCUS $20.71
  • SPB $80.75
  • AVG Volume (30 Days)
  • RCUS 772.4K
  • SPB 508.2K
  • Earning Date
  • RCUS 11-05-2025
  • SPB 08-07-2025
  • Dividend Yield
  • RCUS N/A
  • SPB 3.30%
  • EPS Growth
  • RCUS N/A
  • SPB N/A
  • EPS
  • RCUS N/A
  • SPB 2.71
  • Revenue
  • RCUS $262,000,000.00
  • SPB $2,849,200,000.00
  • Revenue This Year
  • RCUS N/A
  • SPB N/A
  • Revenue Next Year
  • RCUS N/A
  • SPB $0.42
  • P/E Ratio
  • RCUS N/A
  • SPB $21.01
  • Revenue Growth
  • RCUS 6.07
  • SPB N/A
  • 52 Week Low
  • RCUS $6.50
  • SPB $50.73
  • 52 Week High
  • RCUS $18.98
  • SPB $96.62
  • Technical
  • Relative Strength Index (RSI)
  • RCUS 75.43
  • SPB 52.88
  • Support Level
  • RCUS $10.40
  • SPB $54.35
  • Resistance Level
  • RCUS $11.84
  • SPB $57.17
  • Average True Range (ATR)
  • RCUS 0.54
  • SPB 1.53
  • MACD
  • RCUS 0.16
  • SPB -0.01
  • Stochastic Oscillator
  • RCUS 98.35
  • SPB 65.96

About RCUS Arcus Biosciences Inc.

Arcus Biosciences Inc is a clinical-stage biopharmaceutical company. It develops immunotherapies for the treatment of cancer. The company focuses on an ATP-adenosine pathway, which is a key driver of immunosuppression in the tumor microenvironment to create and optimize differentiated small-molecule immuno-oncology product candidates. Its product pipeline includes Domvanalimab, Etrumadenant, AB598, Casdatifan among others. Arcus conducts clinical trials for different types of cancers such as Lung, Colorectal, Pancreatic, and others. The company operates through a single segment which is the business of developing and commercializing immunotherapies.

About SPB Spectrum Brands Holdings Inc.

Spectrum Brands Holdings Inc is consumer products and home essentials company. The company is a supplier of consumer batteries, residential locksets, residential builders' hardware, grooming products and personal care products. The company manages the businesses in product-focused segments; Home and Personal Care, global Pet Care, and Home and Garden. The Company manufactures, markets and distributes its products globally in the North America, Europe, Middle East & Africa, Latin America, and Asia-Pacific.

Share on Social Networks: